1Hansson GK.Immune mechanisms in atherosclerosis[J].Artherio- scler Thromb Vasc Biol,2001,21(2): 1876-1890.
2Anderson JL,Adams CD,Antman EM,et al.ACC/AHA 2007 guide- lines for the management of patients with unstable angina/non-ST- Elevation myocardial infarction[J].J Am Coil Cardiol,2007,50(7): 1-157.
3王吉耀．内科学[M]．北京：人民卫生出版社，2006：575—580．
4Mendis S,Ranatunga P.Heperhomocysteinaemia in Srilandkan patients with coronary artery disease[J].Ceylon Med J,2002,47(3): 89-92.
6Henn V, Steinbach S,Buchner K,et al.The inflammatory action of CD4o ligand(CD4154) expressed on activated human platelets is temporally limited by co-expressed CD40[J].Blood,2001,98(6): 1047 - 1054.
7Carlichs CD,Eskafi S,Raaz D,et al.Patients with acute coronary syndromes express enhanced CD40 ligand/CDm on platelets[J]. Heart,2001,86(5):649-655.
4Garlichs CD,John S,Schmeisser A,et al.Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia[J].Circulation,2001,104 (20):2395-2400.
10Melter M,Reinders ME,Sho M,et al.Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo[J].Blood,2000,96(12):3801 -3808.
